All News

Poor sleep quality may directly increase the headache-related impact in both patients with migraine and patients with tension-type headache, according to a study published in the Journal of Clinical Neurology. Poor sleep quality may also indirectly increase headache frequency and severity in patients with migraine.

Experts from Florida Cancer Specialists cover how the COVID-19 pandemic is transforming telemedicine in oncology by addressing billing, operations, training and provider perspectives in this webinar presented on Monday, April 20, 2020.

A new Gallup poll found that 1 of 7 Americans (14%) reported they would avoid seeking healthcare for a fever and dry cough—common symptoms of the coronavirus disease 2019 (COVID-19)—for themselves or a family member due to cost concerns. Totaled, this percentage amounts to millions of Americans.

Sachin Jain, chief executive officer of CareMore and Aspire Health, announced he will step down from both companies; HHS launches a new coronavirus disease 2019 (COVID-19) Uninsured Program Portal; evidence suggests surgical mask use among healthcare workers are putting them at risk of COVID-19 infection.

The US Supreme Court ruled in favor of health insurers seeking $12 billion from the federal government under the risk corridors program set up by the Affordable Care Act (ACA).

The lipid dioleoyl-phosphatidylglycerol accelerates healing of corneal epithelial wounds, according to a study published in Investigative Ophthalmology & Visual Science.

Delayed school start times were shown to increase sleep duration among adolescents and lessen the need for catch-up sleep during the weekend, which may assist in addressing nationwide sleep deficits in these populations.

According to the most recent PwC Health Research Institute Consumer Survey results, the top consumer concerns for the post–coronavirus disease 2019 (COVID-19) period are overall health and financial well-being, with 32% saying health-related spending adjustments have already occurred or are in the planning stages.

We spoke with Dr Mark Fendrick, co-editor-in-chief of The American Journal of Managed Care®, and director of the University of Michigan Center for Value-Based Insurance Design, or V-BID, on how the principles of V-BID can be used to make a real difference for the millions of American families financially struggling with the impacts of coronavirus disease 2019 (COVID-19) and can help shape the new healthcare delivery landscape after the pandemic.

President Trump insisted that Alex Azar would remain HHS secretary amid reports of his imminent firing; an analysis found that several nursing homes have mismanaged the threat of the coronavirus disease 2019 (COVID-19) in residents and staff; rural populations have been left stranded as several for-profit hospitals have closed amid the the COVID-19 pandemic.

An international team of investigators recently tried to answer this question, focusing on women with diagnosed early-stage disease and considered obese, with a body mass index above 30 kg/m2.

What relationship does the existence of comorbidities have on multiple sclerosis-related hospitalizations?

Site of care made a difference in chemotherapy costs.

Artificial intelligence and deep learning have advanced to the point where they can play a significant role in cancer care, but fully integrating the technology into the clinic remains a challenge.

High-flow nasal therapy (HFNT), often used for stable patients, can reduce hospital readmission for acute exacerbations for chronic obstructive pulmonary disease (COPD).

A new article outlining the experience of a patient with a history of multiple myeloma (MM) who contracted coronavirus disease 2019 (COVID-19) shows the interleukin-6 receptor inhibitor tocilizumab was an effective therapy.

A range of new research is helping scientists better understand psoriasis while also raising new questions. One approach is looking at how the gut microbiome affects the disease.

Patients with lymphoma have better odds of survival now than they did 20 years ago, according to new research. The data also help explain which types of cancer continue to be the most challenging.

Gathering the opinions of hospital pharmacists regarding the treatment of multiple sclerosis can be key for successful, multidisciplinary management of the disease, according to results from a focus group.

Despite significant burden and symptoms, many individuals with migraine have never used acute prescription pain medication to treat the condition, according to study results published in Mayo Clinic Proceedings.

Although the results have to be confirmed in a larger clinical trial, the researchers hope that the biomarker could be a noninvasive marker of a rare pediatric liver disease.

Patients who research medical information online are likely to be more concerned about switching from originator products to biosimilars, according to the study.

Chimeric antigen receptor (CAR) T-cell therapy has been shown to improve health-related quality of life in patients with relapsed/refractory diffuse large B-cell lymphoma (LBCL). Currently, CAR T-cell therapies are primarily administered in inpatient settings. In a study published in JAMA Network Open, researchers found CAR T-cell therapy administered to patients with relapsed or refractory LBCL in outpatient settings was associated with lower estimated overall costs.

Online systems, including telehealth, are imperative to maintaining optimal care for patients with multiple sclerosis (MS) during the coronavirus disease 2019 (COVID-19) pandemic, said June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers, in an interview with The American Journal of Managed Care® (AJMC®).

A number of advances have been made in recent years in our understanding of the genetics of psoriatic diseases and psoriatic arthritis specifically. However, those advances have yet to translate into clinically meaningful insights.

A new study based on treatment of patients with chronic lymphocytic leukemia (CLL) in mostly community settings challenges earlier findings about the superiority of a common therapeutic approach and also makes a strong case for ibrutinib.

Chronic obstructive pulmonary disease (COPD) is not an independent risk factor for metabolic disorders, according to a recent report.